{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:52:41Z","timestamp":1793253161728,"version":"4.5.0"},"reference-count":452,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2320108022"],"award-info":[{"award-number":["2320108022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82322076"],"award-info":[{"award-number":["82322076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405506"],"award-info":[{"award-number":["82405506"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jare.2025.08.031","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:20:27Z","timestamp":1755876027000},"page":"869-896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Serum uric acid and its metabolism-a vital factor in the inflammatory transformation of cancer"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5680-4798","authenticated-orcid":false,"given":"Zongping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0441-7500","authenticated-orcid":false,"given":"Hanchen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2025.08.031_b0005","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.3390\/nu12092600","article-title":"Association between serum uric acid levels, nutritional and antioxidant status in patients on hemodialysis","volume":"12","author":"Dom\u00ednguez-Zambrano","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jare.2025.08.031_b0010","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/mol.110.070607","article-title":"Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signalling hypothesis","volume":"79","author":"Wu","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","article-title":"Asymptomatic hyperuricaemia: a silent activator of the innate immune system","volume":"16","author":"Joosten","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103546","article-title":"Serum metabolomic profiling uncovered metabolic shifts in individuals upon moderate-altitude exposure and identified the potentiality of beta-alanine to ameliorate hyperuricemia","volume":"81","author":"Chen","year":"2025","journal-title":"Redox Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41584-025-01228-7","article-title":"Hyperuricaemia and gout in the Pacific","volume":"21","author":"G\u00e9rard","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.119.13643","article-title":"Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 years","volume":"75","author":"Virdis","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jare.2025.08.031_b0035","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/metabo14030164","article-title":"Serum uric acid\/serum creatinine ratio and cardiovascular mortality in diabetic individuals\u2014the uric acid right for heart health (URRAH) project","volume":"14","author":"D\u2019Elia","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.jare.2025.08.031_b0040","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.numecd.2022.01.028","article-title":"Serum uric acid levels threshold for mortality in diabetic individuals: the URic acid right for heArt Health (URRAH) project","volume":"32","author":"Masulli","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jare.2025.08.031_b0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2017.03.008","article-title":"On the non-linear association between serum uric acid levels and all-cause mortality rate in patients with type 2 diabetes mellitus","volume":"260","author":"Lamacchia","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jare.2025.08.031_b0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coi.2009.12.004","article-title":"The inflammasomes: mechanisms of activation and function","volume":"22","author":"Latz","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jare.2025.08.031_b0055","first-page":"458","article-title":"Relationship between hyperuricemia, HSP70 and NLRP3 inflammasome in arterial hypertension","volume":"93","author":"Rodr\u00edguez-Iturbe","year":"2023","journal-title":"Arch Cardiol Mex"},{"key":"10.1016\/j.jare.2025.08.031_b0060","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","article-title":"A 360\u00b0 view of the inflammasome: mechanisms of activation, cell death, and diseases","volume":"186","author":"Barnett","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jare.2025.08.031_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101070","article-title":"Metabolic syndrome and cancer risk: the role of xanthine oxidoreductase","volume":"21","author":"Battelli","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/BOR.0000000000000028","article-title":"Definition of hyperuricemia and gouty conditions","volume":"26","author":"Bardin","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006503","article-title":"LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma","volume":"13","author":"Cai","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jare.2025.08.031_b0080","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.1184003","article-title":"The NLRP3 inflammasome: a sensor for metabolic danger?","volume":"327","author":"Schroder","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jare.2025.08.031_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.692142","article-title":"Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis","volume":"11","author":"Kartikasari","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b0090","first-page":"278","article-title":"Uric acid as a novel component of metabolic syndrome","volume":"9","author":"Bowden","year":"2023","journal-title":"Int J Clin Cardiol"},{"key":"10.1016\/j.jare.2025.08.031_b0095","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41401-021-00800-7","article-title":"The double faced role of xanthine oxidoreductase in cancer","volume":"43","author":"Chen","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jare.2025.08.031_b0100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jare.2017.03.003","article-title":"Physiological functions and pathogenic potential of uric acid: a review","volume":"8","author":"El Ridi","year":"2017","journal-title":"J Adv Res"},{"key":"10.1016\/j.jare.2025.08.031_b0105","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress\u2014relationship with cardiovascular, metabolic, and renal impairment","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b0110","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2741\/3950","article-title":"Uric acid, hyperuricemia and vascular diseases","volume":"17","author":"Jin","year":"2012","journal-title":"Front Biosci"},{"key":"10.1016\/j.jare.2025.08.031_b0115","first-page":"296","article-title":"Purine metabolites and complex diseases: role of genes and nutrients","volume":"24","author":"Nelson","year":"2021","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jare.2025.08.031_b0120","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3389\/fimmu.2018.01697","article-title":"Potential mechanisms connecting purine metabolism and cancer therapy","volume":"9","author":"Yin","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2025.08.031_b0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7150\/ijms.4.83","article-title":"Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout","volume":"4","author":"Cammalleri","year":"2007","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jare.2025.08.031_b0130","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1074\/jbc.M114.628701","article-title":"Quantitative analysis of purine nucleotides indicates that purinosomes increase de novo purine biosynthesis","volume":"290","author":"Zhao","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.08.031_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10409238.2020.1832438","article-title":"Human de novo purine biosynthesis","volume":"56","author":"Pareek","year":"2021","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000355405","article-title":"Uric acid \u2013 key ingredient in the recipe for cardiorenal metabolic syndrome","volume":"3","author":"Chaudhary","year":"2013","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.jare.2025.08.031_b0145","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1038\/s41467-021-27152-4","article-title":"Initiation of cytosolic plant purine nucleotide catabolism involves a monospecific xanthosine monophosphate phosphatase","volume":"12","author":"Heinemann","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.08.031_b0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jare.2025.08.031_b0155","doi-asserted-by":"crossref","first-page":"9221","DOI":"10.3390\/ijms22179221","article-title":"Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease","volume":"22","author":"Yanai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b0160","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00467-013-2549-x","article-title":"Uric acid and the kidney","volume":"29","author":"Fathallah-Shaykh","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jare.2025.08.031_b0165","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.compbiomed.2019.02.014","article-title":"Understanding the structure-function relationship of HPRT1 missense mutations in association with Lesch-Nyhan disease and HPRT1-related gout by in silico mutational analysis","volume":"107","author":"Agrahari","year":"2019","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.jare.2025.08.031_b0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000494360","article-title":"Kelley-seegmiller syndrome: urolithiasis, renal uric acid deposits, and gout: what is the role of the urologist?","volume":"102","author":"Chavarriaga","year":"2019","journal-title":"Urol Int"},{"key":"10.1016\/j.jare.2025.08.031_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01916-y","article-title":"Hyperuricemia and its related diseases: mechanisms and advances in therapy","volume":"9","author":"Du","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.jare.2025.08.031_b0180","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/mnfr.201200714","article-title":"Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics","volume":"57","author":"Vitetta","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jare.2025.08.031_b0185","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3390\/jpm13091409","article-title":"The role of uric acid in human health: insights from the uricase gene","volume":"13","author":"Roman","year":"2023","journal-title":"J Pers Med"},{"key":"10.1016\/j.jare.2025.08.031_b0190","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.08.031_b0195","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11906-020-01116-3","article-title":"Management of hyperuricemia in patients with chronic kidney disease: a focus on renal protection","volume":"22","author":"Kielstein","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jare.2025.08.031_b0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tifs.2022.03.002","article-title":"Natural compounds lower uric acid levels and hyperuricemia: molecular mechanisms and prospective","volume":"123","author":"Feng","year":"2022","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.jare.2025.08.031_b0205","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ki.2010.206","article-title":"A \u201ccomplexity\u201d of urate transporters","volume":"78","author":"Wright","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jare.2025.08.031_b0210","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4081\/aiua.2016.1.38","article-title":"Herbal medicines for urinary stone treatment. A systematic review","volume":"88","author":"Monti","year":"2016","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.jare.2025.08.031_b0215","article-title":"The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics","volume":"11","author":"Wu","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.jare.2025.08.031_b0220","article-title":"The role of the intestine in the development of hyperuricemia","volume":"13","author":"Yin","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2025.08.031_b0225","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.chom.2023.05.011","article-title":"Gut bacterial metabolism contributes to host global purine homeostasis","volume":"31","author":"Kasahara","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jare.2025.08.031_b0230","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/art.42009","article-title":"Association between gut microbiota and elevated serum urate in two independent cohorts","volume":"74","author":"Wei","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b0235","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1080\/10408398.2021.1874287","article-title":"The gut microbiota as a target to control hyperuricemia pathogenesis: potential mechanisms and therapeutic strategies","volume":"62","author":"Wang","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.jare.2025.08.031_b0240","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13075-020-2136-z","article-title":"Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout","volume":"22","author":"Wrigley","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jare.2025.08.031_b0245","article-title":"Gut microbiota remodeling: a promising therapeutic strategy to confront hyperuricemia and gout","volume":"12","author":"Wang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jare.2025.08.031_b0250","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jconrel.2023.09.011","article-title":"Gout therapeutics and drug delivery","volume":"362","author":"Peng","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.jare.2025.08.031_b0255","doi-asserted-by":"crossref","first-page":"19966","DOI":"10.1021\/acs.jmedchem.4c01260","article-title":"Recent progress and future perspectives on anti-hyperuricemic agents","volume":"67","author":"Sun","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.jare.2025.08.031_b0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40620-018-0546-7","article-title":"The effect of polymorphism of uric acid transporters on uric acid transport","volume":"32","author":"Wang","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.jare.2025.08.031_b0265","doi-asserted-by":"crossref","first-page":"F527","DOI":"10.1152\/ajprenal.00134.2012","article-title":"Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses","volume":"303","author":"Witkowska","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jare.2025.08.031_b0270","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/15257770.2011.623685","article-title":"Pathogenic GLUT9 mutations causing renal hypouricemia type 2 (RHUC2)","volume":"30","author":"Kawamura","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.jare.2025.08.031_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109977","article-title":"A review on gout: looking back and looking ahead","volume":"117","author":"Tao","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b0280","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1039\/C9FO02246E","article-title":"Anti-hyperuricemic potential of stevia (Stevia rebaudiana Bertoni) residue extract in hyperuricemic mice","volume":"11","author":"Mehmood","year":"2020","journal-title":"Food Funct"},{"key":"10.1016\/j.jare.2025.08.031_b0285","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/art.38884","article-title":"NPT1\/SLC17A1 is a renal urate exporter in humans and its common gain-of-function variant decreases the risk of renal underexcretion gout","volume":"67","author":"Chiba","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b0290","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1080\/13880209.2016.1195847","article-title":"Uric acid transporters hiding in the intestine","volume":"54","author":"Xu","year":"2016","journal-title":"Pharm Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0295","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/1440-1681.13539","article-title":"An update of genetics, co-morbidities and management of hyperuricaemia","volume":"48","author":"Zhu","year":"2021","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jare.2025.08.031_b0300","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1212\/WNL.0000000000207825","article-title":"Uric acid: a translational journey in cerebroprotection that spanned preclinical and human data","volume":"101","author":"Leira","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jare.2025.08.031_b0305","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.3390\/cancers14194959","article-title":"The good, the bad and the new about uric acid in cancer","volume":"14","author":"Allegrini","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jare.2025.08.031_b0310","article-title":"Gut microecology: effective targets for natural products to modulate uric acid metabolism","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102137","article-title":"Purinergic signaling in the modulation of redox biology","volume":"47","author":"Savio","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0320","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s42255-021-00454-z","article-title":"Umami-induced obesity and metabolic syndrome is mediated by nucleotide degradation and uric acid generation","volume":"3","author":"Andres-Hernando","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.jare.2025.08.031_b0325","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/cam4.601","article-title":"Xanthine oxidoreductase in cancer: more than a differentiation marker","volume":"5","author":"Battelli","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.jare.2025.08.031_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101882","article-title":"Xanthine oxidoreductase: one enzyme for multiple physiological tasks","volume":"41","author":"Bortolotti","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0335","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41440-021-00724-z","article-title":"Which is more important, xanthine oxidase activity or uric acid itself, in the risk for cardiovascular disease?","volume":"44","author":"Tsuchihashi","year":"2021","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jare.2025.08.031_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110795","article-title":"Recent advances in fructose intake and risk of hyperuricemia","volume":"131","author":"Zhang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jare.2025.08.031_b0345","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3389\/fgene.2019.00945","article-title":"Heterogeneity in metabolic responses to dietary fructose","volume":"10","author":"Hou","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.jare.2025.08.031_b0350","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/nu9040395","article-title":"Fructose intake, serum uric acid, and cardiometabolic disorders: a critical review","volume":"9","author":"Caliceti","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.jare.2025.08.031_b0355","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cmet.2020.05.012","article-title":"Deletion of fructokinase in the liver or in the intestine reveals differential effects on sugar-induced metabolic dysfunction","volume":"32","author":"Andres-Hernando","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.08.031_b0360","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s42255-020-0222-9","article-title":"The small intestine shields the liver from fructose-induced steatosis","volume":"2","author":"Jang","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.jare.2025.08.031_b0365","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI42344","article-title":"Uric acid transport and disease","volume":"120","author":"So","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2025.08.031_b0370","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.937855","article-title":"Trends in the contribution of genetic susceptibility loci to hyperuricemia and gout and associated novel mechanisms","volume":"10","author":"Zhao","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0375","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12916-017-0878-5","article-title":"The genetics of gout: towards personalised medicine?","volume":"15","author":"Dalbeth","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.jare.2025.08.031_b0380","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12881-020-01147-2","article-title":"The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis","volume":"21","author":"Lukkunaprasit","year":"2020","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jare.2025.08.031_b0385","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.2337\/dc08-0349","article-title":"Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI","volume":"31","author":"Brandst\u00e4tter","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jare.2025.08.031_b0390","article-title":"Sex differences in urate handling","volume":"21","author":"Vl","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b0395","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/imr.12833","article-title":"Urate-induced immune programming: consequences for gouty arthritis and hyperuricemia","volume":"294","author":"Cab\u0103u","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jare.2025.08.031_b0400","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.3390\/jcm12227159","article-title":"Women with metabolic syndrome and unhealthy lifestyle factors are at a higher risk for hyperuricemia","volume":"12","author":"Kang","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jare.2025.08.031_b0405","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13075-021-02444-8","article-title":"The comparative effect of exposure to various risk factors on the risk of hyperuricaemia: diet has a weak causal effect","volume":"23","author":"Topless","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jare.2025.08.031_b0410","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.41067","article-title":"Population impact attributable to modifiable risk factors for hyperuricemia","volume":"72","author":"Choi","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b0415","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3390\/ijms22062786","article-title":"Medically important alterations in transport function and trafficking of ABCG2","volume":"22","author":"Homolya","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b0420","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ceb.2019.05.005","article-title":"Putting the brakes on the cell cycle: mechanisms of cellular growth arrest","volume":"60","author":"Pack","year":"2019","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0425","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/v12040382","article-title":"SAMHD1 functions and human diseases","volume":"12","author":"Coggins","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jare.2025.08.031_b0430","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.celrep.2017.08.008","article-title":"SAMHD1 promotes DNA End resection to facilitate DNA repair by homologous recombination","volume":"20","author":"Daddacha","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2025.08.031_b0435","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ajhg.2020.01.008","article-title":"The biology of cell-free DNA fragmentation and the roles of DNASE1, DNASE1L3, and DFFB","volume":"106","author":"Han","year":"2020","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jare.2025.08.031_b0440","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fphar.2018.00627","article-title":"Who is who in adenosine transport","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b0445","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1074\/jbc.RA118.007266","article-title":"DNA damage response activates respiration and thereby enlarges dNTP pools to promote cell survival in budding yeast","volume":"294","author":"Bu","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.08.031_b0450","first-page":"771","article-title":"Cell death response to DNA damage","volume":"92","author":"Wang","year":"2019","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jare.2025.08.031_b0455","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41580-020-0232-1","article-title":"The clearance of dead cells by efferocytosis","volume":"21","author":"Boada-Romero","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0460","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/cdd.2015.172","article-title":"The clearance of dying cells: table for two","volume":"23","author":"Green","year":"2016","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jare.2025.08.031_b0465","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.3109\/10428194.2013.874010","article-title":"Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome?","volume":"55","author":"Canet","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jare.2025.08.031_b0470","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood-2017-07-746396","article-title":"DNA damage responses and p53 in the aging process","volume":"131","author":"Ou","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jare.2025.08.031_b0475","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026070","article-title":"p53 in the DNA-Damage-Repair Process","volume":"6","author":"Williams","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jare.2025.08.031_b0480","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b0485","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/cells8020100","article-title":"Mitochondrial DNA integrity: role in health and disease","volume":"8","author":"Sharma","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jare.2025.08.031_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2024.119612","article-title":"Blood mercury mediates the associations between fish consumption and serum uric acid levels among Chinese adults: a nationally representative study","volume":"260","author":"Wu","year":"2024","journal-title":"Environ Res"},{"key":"10.1016\/j.jare.2025.08.031_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.104993","article-title":"Combined exposure to lead, cadmium, mercury, and arsenic and kidney health in adolescents age 12-19 in NHANES 2009-2014","volume":"131","author":"Sanders","year":"2019","journal-title":"Environ Int"},{"key":"10.1016\/j.jare.2025.08.031_b0500","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/ard-2023-225389","article-title":"Changes in alcohol intake and serum urate changes: longitudinal analyses of annual medical examination database","volume":"83","author":"Fukui","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2025.08.031_b0505","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nut.2010.02.014","article-title":"Fructose and metabolic diseases: new findings, new questions","volume":"26","author":"Tappy","year":"2010","journal-title":"Nutrition"},{"key":"10.1016\/j.jare.2025.08.031_b0510","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jacc.2015.08.025","article-title":"Fructose and cardiometabolic health: what the evidence from sugar-sweetened beverages tells us","volume":"66","author":"Malik","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jare.2025.08.031_b0515","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024171","article-title":"Important food sources of fructose-containing sugars and incident gout: a systematic review and meta-analysis of prospective cohort studies","volume":"9","author":"Ayoub-Charette","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jare.2025.08.031_b0520","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/ki.2009.500","article-title":"Sugar-sweetened soda consumption, hyperuricemia, and kidney disease","volume":"77","author":"Bomback","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jare.2025.08.031_b0525","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/nu10080981","article-title":"Sugar-sweetened soft drinks and fructose consumption are associated with hyperuricemia: cross-sectional analysis from the Brazilian longitudinal study of adult health (ELSA-Brasil)","volume":"10","author":"Siqueira","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.jare.2025.08.031_b0530","doi-asserted-by":"crossref","DOI":"10.1089\/jmf.2024.0139","article-title":"100% fruit juice intake, glucose profile, and uric acid: a systematic review","author":"D\u2019Elia","year":"2025","journal-title":"J Med Food"},{"key":"10.1016\/j.jare.2025.08.031_b0535","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.3390\/nu13092956","article-title":"Distinct impact of natural sugars from fruit juices and added sugars on caloric intake, body weight, glycaemia, oxidative stress and glycation in diabetic rats","volume":"13","author":"Monteiro-Alfredo","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jare.2025.08.031_b0540","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1093\/nutrit\/nuae036","article-title":"Health effects of drinking 100% juice: an umbrella review of systematic reviews with meta-analyses","volume":"83","author":"Beckett","year":"2025","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jare.2025.08.031_b0545","first-page":"1","article-title":"The effect of consumption of a nopal cactus fruit juice on C-reactive protein levels in healthy adults: results from a randomized, double-blind","volume":"6","author":"Jensen","year":"2016","journal-title":"Controlled Clinical Pilot Study EJNFS"},{"key":"10.1016\/j.jare.2025.08.031_b0550","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/nu14040821","article-title":"Health benefits of apple juice consumption: a review of interventional trials on humans","volume":"14","author":"Vall\u00e9e Marcotte","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jare.2025.08.031_b0555","doi-asserted-by":"crossref","unstructured":"GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 2024;23:973\u20131003. DOI: 10.1016\/S1474-4422(24)00369-7.","DOI":"10.1016\/S1474-4422(24)00369-7"},{"key":"10.1016\/j.jare.2025.08.031_b0560","doi-asserted-by":"crossref","first-page":"11078","DOI":"10.3390\/ijms252011078","article-title":"Double-edged sword effect of diet and nutrition on carcinogenic molecular pathways in breast cancer","volume":"25","author":"Neagu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b0565","article-title":"Pro-inflammatory diets promote the formation of hyperuricemia","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jare.2025.08.031_b0570","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.3390\/nu12113503","article-title":"Hybrid dietary-blood inflammatory profiles and postmenopausal breast cancer: a case-control study","volume":"12","author":"Stasiewicz","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jare.2025.08.031_b0575","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1218166","article-title":"A cross-sectional study on the association between dietary inflammatory index and hyperuricemia based on NHANES 2005\u20132018","volume":"10","author":"Wang","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.jare.2025.08.031_b0580","first-page":"1344","article-title":"Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review","volume":"27","author":"Li","year":"2018","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.jare.2025.08.031_b0585","first-page":"1","article-title":"Effects of dietary factors on hyperuricaemia and gout: a systematic review and meta-analysis of observational studies","author":"Chi","year":"2024","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.jare.2025.08.031_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102271","article-title":"U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia","volume":"51","author":"Crawley","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0595","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-024-00542-w","article-title":"Tumour lysis syndrome","volume":"10","author":"Howard","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jare.2025.08.031_b0600","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jhep.2015.01.019","article-title":"Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds","volume":"62","author":"Xu","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jare.2025.08.031_b0605","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","article-title":"Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the national kidney foundation","volume":"71","author":"Johnson","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jare.2025.08.031_b0610","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1210\/jc.2015-2527","article-title":"Serum uric acid levels and risk of metabolic syndrome: a dose-response meta-analysis of prospective studies","volume":"100","author":"Yuan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jare.2025.08.031_b0615","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11926-011-0162-1","article-title":"The role of uric acid as an endogenous danger signal in immunity and inflammation","volume":"13","author":"Ghaemi-Oskouie","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jare.2025.08.031_b0620","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.08.031_b0625","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/08820139.2013.864667","article-title":"Pro-inflammatory effects of uric acid in the gastrointestinal tract","volume":"43","author":"Crane","year":"2014","journal-title":"Immunol Invest"},{"key":"10.1016\/j.jare.2025.08.031_b0630","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1038\/s41598-019-46935-w","article-title":"Crystallized but not soluble uric acid elicits pro-inflammatory response in short-term whole blood cultures from healthy men","volume":"9","author":"Brovold","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.08.031_b0635","article-title":"The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2025.08.031_b0640","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding Toll-like receptors: recent insights and perspectives in innate immunity","volume":"57","author":"Kawai","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jare.2025.08.031_b0645","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b0650","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/rheumatology\/ker524","article-title":"Microcrystals as DAMPs and their role in joint inflammation","volume":"51","author":"Busso","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jare.2025.08.031_b0655","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3899\/jrheum.180855","article-title":"Precipitation of soluble uric acid is necessary for in vitro activation of the NLRP3 inflammasome in primary human monocytes","volume":"46","author":"Alberts","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b0660","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbrc.2020.12.097","article-title":"Uric acid inhibits HMGB1-TLR4-NF-\u03baB signalling to alleviate oxygen-glucose deprivation\/reoxygenation injury of microglia","volume":"540","author":"Wang","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jare.2025.08.031_b0665","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13075-018-1512-4","article-title":"Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K\/Akt signalling pathway","volume":"20","author":"Chen","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jare.2025.08.031_b0670","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/0886022X.2022.2036620","article-title":"Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease","volume":"44","author":"Wang","year":"2022","journal-title":"Ren Fail"},{"key":"10.1016\/j.jare.2025.08.031_b0675","doi-asserted-by":"crossref","first-page":"e805","DOI":"10.1002\/iid3.805","article-title":"Uric acid is independently associated with interleukin-1\u03b2 levels in tear fluid of hyperuricemia and gout patients","volume":"11","author":"Wu","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jare.2025.08.031_b0680","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.08.031_b0685","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/art.27456","article-title":"Role of the leucine-rich repeat domain of cryopyrin\/NALP3 in monosodium urate crystal-induced inflammation in mice","volume":"62","author":"Hoffman","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jare.2025.08.031_b0690","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.4049\/jimmunol.177.9.6370","article-title":"Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals","volume":"177","author":"Scott","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2025.08.031_b0695","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.0105-2896.2009.00851.x","article-title":"Monosodium urate crystals in inflammation and immunity","volume":"233","author":"Shi","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jare.2025.08.031_b0700","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.3390\/cells10123466","article-title":"Alternative splicing of MAPKs in the regulation of signalling specificity","volume":"10","author":"Maik-Rachline","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jare.2025.08.031_b0705","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/embor.2010.160","article-title":"MAPK signalling in cellular metabolism: stress or wellness?","volume":"11","author":"Gehart","year":"2010","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jare.2025.08.031_b0710","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jare.2025.08.031_b0715","doi-asserted-by":"crossref","first-page":"F396","DOI":"10.1152\/ajprenal.00565.2013","article-title":"Activation of ERK1\/2 by NADPH oxidase-originated reactive oxygen species mediates uric acid-induced mesangial cell proliferation","volume":"307","author":"Zhuang","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jare.2025.08.031_b0720","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","article-title":"Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2","volume":"41","author":"Kanellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jare.2025.08.031_b0725","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1681\/ASN.2005050572","article-title":"Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells","volume":"16","author":"Kang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2025.08.031_b0730","doi-asserted-by":"crossref","first-page":"33807","DOI":"10.18632\/oncotarget.16995","article-title":"Pharmacologic targeting ERK1\/2 attenuates the development and progression of hyperuricemic nephropathy in rats","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jare.2025.08.031_b0735","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/10799893.2015.1006332","article-title":"Effects of losartan on expression of monocyte chemoattractant protein-1 (MCP-1) in hyperuricemic nephropathy rats","volume":"35","author":"Yu","year":"2015","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.jare.2025.08.031_b0740","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1159\/000488048","article-title":"Uric acid induces cardiomyocyte apoptosis via activation of calpain-1 and endoplasmic reticulum stress","volume":"45","author":"Yan","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jare.2025.08.031_b0745","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2021.12.307","article-title":"Enterocyte synthesizes and secrets uric acid as antioxidant to protect against oxidative stress via the involvement of Nrf pathway","volume":"179","author":"Wang","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jare.2025.08.031_b0750","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3390\/antiox12051022","article-title":"Activation of NRF2 signalling pathway delays the progression of hyperuricemic nephropathy by reducing oxidative stress","volume":"12","author":"Qiao","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jare.2025.08.031_b0755","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/biom14080978","article-title":"Mechanism of reactive oxygen species-guided immune responses in gouty arthritis and potential therapeutic targets","volume":"14","author":"Zhang","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jare.2025.08.031_b0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175044","article-title":"Research on the effect and underlying molecular mechanism of Cangzhu in the treatment of gouty arthritis","volume":"927","author":"Li","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b0765","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ptr.4997","article-title":"Therapeutic effect of rhizoma dioscoreae nipponicae on gouty arthritis based on the SDF-1\/CXCR 4 and p38 MAPK pathway: an in vivo and in vitro study","volume":"28","author":"Lu","year":"2014","journal-title":"Phytother Res"},{"key":"10.1016\/j.jare.2025.08.031_b0770","doi-asserted-by":"crossref","first-page":"12580","DOI":"10.3390\/ijms222212580","article-title":"Takinib inhibits inflammation in human rheumatoid arthritis synovial fibroblasts by targeting the janus kinase-signal transducer and activator of transcription 3 (JAK\/STAT3) pathway","volume":"22","author":"Panipinto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b0775","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/md19050238","article-title":"Fucoidan from Laminaria japonica inhibits expression of GLUT9 and URAT1 via PI3K\/Akt, JNK and NF-\u03baB pathways in uric acid-exposed HK-2 cells","volume":"19","author":"Zhang","year":"2021","journal-title":"Mar Drugs"},{"key":"10.1016\/j.jare.2025.08.031_b0780","article-title":"Punicalagin attenuates hyperuricemia via restoring hyperuricemia-induced renal and intestinal dysfunctions","author":"Han","year":"2024","journal-title":"J Adv Res"},{"key":"10.1016\/j.jare.2025.08.031_b0785","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/10799893.2021.1931320","article-title":"Uric acid can enhance MAPK pathway-mediated proliferation in rat primary vascular smooth muscle cells via controlling of mitochondria and caspase-dependent cell death","volume":"42","author":"Do\u011fru","year":"2022","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.jare.2025.08.031_b0790","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1142\/S0192415X20500718","article-title":"Lipophilic extract and tanshinone IIA derived from salvia miltiorrhiza attenuate uric acid nephropathy through suppressing oxidative stress-activated MAPK pathways","volume":"48","author":"Zhang","year":"2020","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.jare.2025.08.031_b0795","doi-asserted-by":"crossref","first-page":"E1032","DOI":"10.1152\/ajpendo.00518.2020","article-title":"High uric acid induces liver fat accumulation via ROS\/JNK\/AP-1 signalling","volume":"320","author":"Xie","year":"2021","journal-title":"Am J Phys Endocrinol Metab"},{"key":"10.1016\/j.jare.2025.08.031_b0800","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/labinvest.2014.98","article-title":"Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes","volume":"94","author":"Choi","year":"2014","journal-title":"Lab Invest"},{"key":"10.1016\/j.jare.2025.08.031_b0805","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcmgh.2018.10.016","article-title":"Resolving the paradox of hepatic insulin resistance","volume":"7","author":"Santoleri","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jare.2025.08.031_b0810","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/dom.15466","article-title":"Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: the Kangbuk samsung health study","volume":"26","author":"Cho","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jare.2025.08.031_b0815","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/liv.13329","article-title":"Hyperuricaemia and risk of nonalcoholic fatty liver disease: a meta-analysis","volume":"37","author":"Wijarnpreecha","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jare.2025.08.031_b0820","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12944-022-01771-2","article-title":"The relationship between NAFLD and retinol-binding protein 4 - an updated systematic review and meta-analysis","volume":"22","author":"Hu","year":"2023","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jare.2025.08.031_b0825","doi-asserted-by":"crossref","first-page":"14325","DOI":"10.1038\/srep14325","article-title":"Dose-response relationship of serum uric acid with metabolic syndrome and non-alcoholic fatty liver disease incidence: a meta-analysis of prospective studies","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.08.031_b0830","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1074\/jbc.RA118.006158","article-title":"Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats","volume":"294","author":"Sanchez-Lozada","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.08.031_b0835","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature01137","article-title":"A central role for JNK in obesity and insulin resistance","volume":"420","author":"Hirosumi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.08.031_b0840","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/ATVBAHA.113.302214","article-title":"Mice heterozygous for the xanthine oxidoreductase gene facilitate lipid accumulation in adipocytes","volume":"34","author":"Murakami","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0845","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/21623945.2015.1005525","article-title":"Does inorganic nitrate say NO to obesity by browning white adipose tissue?","volume":"4","author":"Roberts","year":"2015","journal-title":"Adipocyte"},{"key":"10.1016\/j.jare.2025.08.031_b0850","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41388-023-02907-z","article-title":"ROS production by mitochondria: function or dysfunction?","volume":"43","author":"Palma","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2025.08.031_b0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109587","article-title":"A small-molecule JNK inhibitor JM-2 attenuates high-fat diet-induced non-alcoholic fatty liver disease in mice","volume":"115","author":"Jin","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b0860","doi-asserted-by":"crossref","first-page":"E436","DOI":"10.1152\/ajpendo.00629.2007","article-title":"Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice","volume":"295","author":"Yu","year":"2008","journal-title":"Am J Phys Endocrinol Metab"},{"key":"10.1016\/j.jare.2025.08.031_b0865","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.immuni.2008.09.013","article-title":"Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells","volume":"29","author":"Ng","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jare.2025.08.031_b0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102189","article-title":"Phosphorylation on Syk Y342 is important for both ITAM and hemITAM signaling in platelets","volume":"298","author":"Kostyak","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.08.031_b0875","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s10020-023-00756-w","article-title":"Maresin1 ameliorates MSU crystal-induced inflammation by upregulating Prdx5 expression","volume":"29","author":"Jiang","year":"2023","journal-title":"Mol Med"},{"key":"10.1016\/j.jare.2025.08.031_b0880","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jare.2025.08.031_b0885","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0891-5849(02)00956-5","article-title":"Structure and function of xanthine oxidoreductase: where are we now?","volume":"33","author":"Harrison","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jare.2025.08.031_b0890","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","article-title":"New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity","volume":"319","author":"Furuhashi","year":"2020","journal-title":"Am J Phys Endocrinol Metab"},{"key":"10.1016\/j.jare.2025.08.031_b0895","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13105-021-00869-y","article-title":"Evidence for the effect of soluble uric acid in augmenting endoplasmic reticulum stress markers in human peripheral blood mononuclear cells","volume":"78","author":"Ebrahimi","year":"2022","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.jare.2025.08.031_b0900","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41580-023-00645-4","article-title":"Understanding mechanisms of antioxidant action in health and disease","volume":"25","author":"Halliwell","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0905","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/annrheumdis-2021-eular.2316","article-title":"Pos0133 monosodium urate crystals reduce human ligament cells Viability through increase of ros production","volume":"80","author":"Huang","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2025.08.031_b0910","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0915","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41577-022-00787-0","article-title":"Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases","volume":"23","author":"Wigerblad","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jare.2025.08.031_b0920","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/imr.12839","article-title":"Inflammasomes contributing to inflammation in arthritis","volume":"294","author":"Spel","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jare.2025.08.031_b0925","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jare.2025.08.031_b0930","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1423-0127-21-3","article-title":"Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications","volume":"21","author":"Hsieh","year":"2014","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jare.2025.08.031_b0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102573","article-title":"The mechanism and significance of the conversion of xanthine dehydrogenase to xanthine oxidase in mammalian secretory gland cells","volume":"59","author":"Kusano","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0940","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/jcp.31038","article-title":"Hyperuricemia promotes the progression of atherosclerosis by activating endothelial cell pyroptosis via the ROS\/NLRP3 pathway","volume":"238","author":"He","year":"2023","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jare.2025.08.031_b0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213005","article-title":"Monosodium urate crystals with controlled shape and aspect ratio for elucidating the pathological progress of acute gout","volume":"139","author":"Chen","year":"2022","journal-title":"Biomater Adv"},{"key":"10.1016\/j.jare.2025.08.031_b0950","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1089\/ars.2020.8257","article-title":"Loop between NLRP3 inflammasome and reactive oxygen species","volume":"36","author":"Dominic","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jare.2025.08.031_b0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103021","article-title":"Inhibition of xanthine oxidase by allopurinol suppresses HMGB1 secretion and ameliorates experimental asthma","volume":"70","author":"Wang","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.jare.2025.08.031_b0960","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/1871523011312010011","article-title":"Xanthine oxidase inhibitor febuxostat as a novel agent postulated to act against vascular inflammation","volume":"12","author":"Sab\u00e1n-Ruiz","year":"2013","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"10.1016\/j.jare.2025.08.031_b0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106818","article-title":"A new avenue for enhanced treatment of hyperuricemia and oxidative stress: design, synthesis and biological evaluation of some novel mutual prodrugs involving febuxostat conjugated with different antioxidants","volume":"140","author":"Rashad","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jare.2025.08.031_b0970","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature20597","article-title":"NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer","volume":"540","author":"Karki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.08.031_b0975","article-title":"Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer","author":"Soundararajan","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jare.2025.08.031_b0980","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp8783","article-title":"p53 terminates the regenerative fetal-like state after colitis-associated injury","volume":"10","author":"Hartl","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.jare.2025.08.031_b0985","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240766","article-title":"NFAT5 governs cellular plasticity-driven resistance to KRAS-targeted therapy in pancreatic cancer","volume":"221","author":"Deng","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.jare.2025.08.031_b0990","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.immuni.2024.10.015","article-title":"Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms","volume":"57","author":"Sun","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.jare.2025.08.031_b0995","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/ijms20030676","article-title":"Inflammation and pancreatic cancer: focus on metabolism, cytokines, and immunity","volume":"20","author":"Padoan","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b1000","doi-asserted-by":"crossref","first-page":"C584","DOI":"10.1152\/ajpcell.00600.2006","article-title":"Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress","volume":"293","author":"Sautin","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jare.2025.08.031_b1005","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3899\/jrheum.200497","article-title":"Risk of cancer in middle-aged patients with gout: a nationwide population-based Study in Korea","volume":"48","author":"Lee","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b1010","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3899\/jrheum.210138","article-title":"Among the company that gout keeps, is cancer on the list?","volume":"48","author":"Gelber","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b1015","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000040234","article-title":"Association between gout and cancers: a systematic review and meta-analysis","volume":"103","author":"Tian","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jare.2025.08.031_b1020","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.608311","article-title":"Serum uric acid levels and risk of eight site-specific cancers: a mendelian randomization study","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.jare.2025.08.031_b1025","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s12094-023-03314-2","article-title":"Analysis of the prognostic value of uric acid on the efficacy of immunotherapy in patients with primary liver cancer","volume":"26","author":"Rao","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.amjms.2023.11.013","article-title":"Effect of serum uric acid and gout on the incidence of colorectal cancer: a meta-analysis","volume":"367","author":"Liu","year":"2024","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jare.2025.08.031_b1035","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1007\/s00432-023-04725-y","article-title":"J-shaped association between uric acid and breast cancer risk: a prospective case\u2013control study","volume":"149","author":"Fan","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1040","doi-asserted-by":"crossref","first-page":"26165","DOI":"10.1038\/s41598-024-77788-7","article-title":"Investigating the causal association between serum uric acid levels and gastric cancer risk: a Mendelian randomization study","volume":"14","author":"Zhao","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.08.031_b1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155850","article-title":"Interleukin-1 (IL-1) and the inflammasome in cancer","volume":"153","author":"Pretre","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.jare.2025.08.031_b1050","doi-asserted-by":"crossref","first-page":"10801","DOI":"10.1038\/s41467-024-55083-3","article-title":"Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors","volume":"15","author":"Orehek","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.08.031_b1055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/biomedicines13010203","article-title":"Conventional chemotherapy and inflammation: What is the role of the inflammasome in the tumor microenvironment?","volume":"13","author":"Colarusso","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.jare.2025.08.031_b1060","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.3390\/ijms19113598","article-title":"Emerging role of purine metabolizing enzymes in brain function and tumors","volume":"19","author":"Garcia-Gil","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b1065","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.canep.2010.06.014","article-title":"A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer","volume":"34","author":"Hammarsten","year":"2010","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.jare.2025.08.031_b1070","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.2147\/OTT.S175112","article-title":"Elevated urinary 8-oxo-7,8-dihydro-2\u2019-deoxyguanosine and serum uric acid are associated with progression and are prognostic factors of colorectal cancer","volume":"11","author":"Mao","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jare.2025.08.031_b1075","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.3390\/cancers15235623","article-title":"Characteristics of ABCC4 and ABCG2 high expression subpopulations in CRC-a new opportunity to predict therapy response","volume":"15","author":"Kryczka","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jare.2025.08.031_b1080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002256","article-title":"A novel TOX3-WDR5-ABCG2 signalling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance","volume":"21","author":"Hao","year":"2023","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jare.2025.08.031_b1085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1574892817666220112100036","article-title":"Inhibiting the activity of ABCG2 by KU55933 in colorectal cancer","volume":"17","author":"Liu","year":"2022","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.jare.2025.08.031_b1090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13046-024-03255-w","article-title":"SPP1+\u2009macrophages promote head and neck squamous cell carcinoma progression by secreting TNF-\u03b1 and IL-1\u03b2","volume":"43","author":"Liu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jare.2025.08.031_b1095","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","article-title":"IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer","volume":"623","author":"Caronni","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.08.031_b1100","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.7150\/jca.46200","article-title":"Friend or foe? an unrecognized role of uric acid in cancer development and the potential anticancer effects of uric acid-lowering drugs","volume":"11","author":"Mi","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.jare.2025.08.031_b1105","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3390\/ijms19082155","article-title":"Interleukin-1 beta-a friend or foe in malignancies?","volume":"19","author":"Bent","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b1110","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/ph15111442","article-title":"Apigenin ameliorates hyperuricemia and renal injury through regulation of uric acid metabolism and JAK2\/STAT3 signalling pathway","volume":"15","author":"Liu","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jare.2025.08.031_b1115","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signalling pathway in cancers","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1120","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1002\/mc.22691","article-title":"CRH promotes human colon cancer cell proliferation via IL-6\/JAK2\/STAT3 signaling pathway and VEGF-induced tumor angiogenesis","volume":"56","author":"Fang","year":"2017","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jare.2025.08.031_b1125","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/carcin\/bgv123","article-title":"Immunosuppression associated with chronic inflammation in the tumor microenvironment","volume":"36","author":"Wang","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jare.2025.08.031_b1130","doi-asserted-by":"crossref","first-page":"10019","DOI":"10.1158\/0008-5472.CAN-07-2354","article-title":"Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression","volume":"67","author":"Bunt","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2025.08.031_b1135","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1140","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1016\/j.cell.2024.05.011","article-title":"De novo and salvage purine synthesis pathways across tissues and tumors","volume":"187","author":"Tran","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jare.2025.08.031_b1145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2001-1326-1-16","article-title":"Contribution of uric acid to cancer risk, recurrence, and mortality","volume":"1","author":"Fini","year":"2012","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jare.2025.08.031_b1150","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1021\/acs.jproteome.0c00285","article-title":"Liquid chromatography-mass spectrometry-based tissue metabolic profiling reveals major metabolic pathway alterations and potential biomarkers of lung cancer","volume":"19","author":"You","year":"2020","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jare.2025.08.031_b1155","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jhep.2023.06.022","article-title":"The XOR-IDH3\u03b1 axis controls macrophage polarization in hepatocellular carcinoma","volume":"79","author":"Lu","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jare.2025.08.031_b1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174270","article-title":"Xanthine oxidoreductase promotes the progression of colitis-associated colorectal cancer by causing DNA damage and mediating macrophage M1 polarization","volume":"906","author":"Li","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b1165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.08.031_b1170","article-title":"Elevated expression of hypoxanthine guanine phosphoribosyltransferase within malignant tissue","volume":"6","author":"Townsend","year":"2017","journal-title":"Cancer Clin Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ccell.2022.11.013","article-title":"Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer","volume":"41","author":"Teng","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jare.2025.08.031_b1180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40168-024-01826-9","article-title":"Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome","volume":"12","author":"Zhou","year":"2024","journal-title":"Microbiome"},{"key":"10.1016\/j.jare.2025.08.031_b1185","doi-asserted-by":"crossref","first-page":"001","DOI":"10.17352\/2455-5495.000045","article-title":"Gut microbiota alteration in CKD: from toxicity mechanisms to supplementation","volume":"9","author":"Claudia Jackelin","year":"2024","journal-title":"Arch Renal Dis Manag"},{"key":"10.1016\/j.jare.2025.08.031_b1190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00253-023-12953-y","article-title":"Potassium sodium hydrogen citrate intervention on gut microbiota and clinical features in uric acid stone patients","volume":"108","author":"Cao","year":"2024","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.jare.2025.08.031_b1195","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3390\/foods13091371","article-title":"Lacticaseibacillus paracasei JS-3 Isolated from \u201cJiangshui\u201d ameliorates hyperuricemia by regulating gut microbiota and iTS metabolism","volume":"13","author":"Wu","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.jare.2025.08.031_b1200","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1449030","article-title":"Unlocking the power of short-chain fatty acids in ameliorating intestinal mucosal immunity: a new porcine nutritional approach","volume":"14","author":"Liu","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jare.2025.08.031_b1205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ame2.12464","article-title":"Role of short-chain fatty acids in host physiology","volume":"7","author":"Liu","year":"2024","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.jare.2025.08.031_b1210","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1051682","article-title":"The role of gut microbiota in gout: is gut microbiota a potential target for gout treatment","volume":"12","author":"Tong","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jare.2025.08.031_b1215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116553","article-title":"Altered gut metabolites and metabolic reprogramming involved in the pathogenesis of colitis-associated colorectal cancer and the transition of colon \u201cinflammation to cancer.","volume":"253","author":"Wang","year":"2025","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jare.2025.08.031_b1220","doi-asserted-by":"crossref","first-page":"10990","DOI":"10.1523\/JNEUROSCI.1480-16.2016","article-title":"Uric acid induces cognitive dysfunction through hippocampal inflammation in rodents and humans","volume":"36","author":"Shao","year":"2016","journal-title":"J Neurosci"},{"key":"10.1016\/j.jare.2025.08.031_b1225","doi-asserted-by":"crossref","first-page":"e1283","DOI":"10.1038\/cddis.2014.221","article-title":"NF-\u03baB and Nrf2 signalling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis","volume":"5","author":"Yao","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.nutres.2009.03.011","article-title":"Bovine colostrum inhibits nuclear factor \u03baB\u2013mediated proinflammatory cytokine expression in intestinal epithelial cells","volume":"29","author":"An","year":"2009","journal-title":"Nutr Res"},{"key":"10.1016\/j.jare.2025.08.031_b1235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.jare.2025.08.031_b1240","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/s41388-022-02190-4","article-title":"Canonical TGF\u03b2 signalling induces collective invasion in colorectal carcinogenesis through a Snail1- and Zeb1-independent partial EMT","volume":"41","author":"Flum","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2025.08.031_b1245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2016.06.001","article-title":"IL-1\u03b2\/NF-kb signalling promotes colorectal cancer cell growth through miR-181a\/PTEN axis","volume":"604","author":"Hai Ping","year":"2016","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jare.2025.08.031_b1250","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/14728222.2024.2433687","article-title":"miR-181a: regulatory roles, cancer-associated signalling pathway disruptions, and therapeutic potential","volume":"28","author":"McIntyre","year":"2024","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jare.2025.08.031_b1255","article-title":"Cyclooxygenase-2-Prostaglandin E2 pathway: a key player in tumor-associated immune cells","volume":"13","author":"K","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1260","doi-asserted-by":"crossref","first-page":"9474","DOI":"10.1038\/s41598-024-60122-6","article-title":"The effect of metabolism-related lifestyle and clinical risk factors on digestive system cancers in East asian populations: a two-sample Mendelian randomization analysis","volume":"14","author":"Cai","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.08.031_b1265","doi-asserted-by":"crossref","first-page":"42332","DOI":"10.18632\/oncotarget.16198","article-title":"Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study","volume":"8","author":"Yiu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jare.2025.08.031_b1270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ijc.33807","article-title":"High serum uric acid may associate with the increased risk of colorectal cancer in females: a prospective cohort study","volume":"150","author":"Mi","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jare.2025.08.031_b1275","doi-asserted-by":"crossref","first-page":"18867","DOI":"10.1038\/s41598-023-46348-w","article-title":"Hyperuricemia remission after colorectal cancer surgery for colorectal cancer patients","volume":"13","author":"Liu","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.08.031_b1280","article-title":"Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis","volume":"160","author":"S","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jare.2025.08.031_b1285","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41419-024-07095-6","article-title":"GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-\u03b2 signaling pathway","volume":"15","author":"Luo","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1290","article-title":"Combination of pirfenidone and andrographolide ameliorates hepatic stellate cell activation and liver fibrosis by mediating TGF-\u03b2\/Smad Signalling pathway","volume":"2024","author":"Xu","year":"2024","journal-title":"Anal Cell Pathol (Amst)"},{"key":"10.1016\/j.jare.2025.08.031_b1295","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.cmet.2021.09.010","article-title":"Molecular aspects of fructose metabolism and metabolic disease","volume":"33","author":"Herman","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.08.031_b1300","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106407","article-title":"Chronic kidney disease: Which role for xanthine oxidoreductase activity and products?","volume":"184","author":"Polito","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jare.2025.08.031_b1305","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2337\/db18-1198","article-title":"Hepatocyte-specific ablation or whole-body inhibition of xanthine oxidoreductase in mice corrects obesity-induced systemic hyperuricemia without improving metabolic abnormalities","volume":"68","author":"Harmon","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.jare.2025.08.031_b1310","article-title":"Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis","volume":"3","author":"Shepherd","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jare.2025.08.031_b1315","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.freeradbiomed.2024.09.023","article-title":"Unconjugated bilirubin promotes uric acid restoration by activating hepatic AMPK pathway","volume":"224","author":"Zhang","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jare.2025.08.031_b1320","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.apsb.2024.04.024","article-title":"KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2","volume":"14","author":"Peng","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jare.2025.08.031_b1325","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1096\/fj.13-243634","article-title":"Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids","volume":"28","author":"Cicerchi","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.jare.2025.08.031_b1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118569","article-title":"D-glucaro-1,4-lactone improves diethylnitrosamine induced hepatocellular carcinoma in rats via the uric acid-ROS pathway","volume":"334","author":"Cai","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b1335","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jare.2025.08.031_b1340","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12885-025-13597-z","article-title":"Global, regional, and national burden of pancreatic cancer from 1990 to 2021, its attributable risk factors, and projections to 2050: a systematic analysis of the global burden of disease study 2021","volume":"25","author":"Li","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jare.2025.08.031_b1345","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jare.2025.08.031_b1350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104730","article-title":"Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients","volume":"9","author":"Stotz","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2025.08.031_b1355","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s12032-010-9480-9","article-title":"Clinical significance of the immunostimulatory MHC class I chain-related molecule a and NKG2D receptor on NK cells in pancreatic cancer","volume":"28","author":"Duan","year":"2011","journal-title":"Med Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1360","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1471-2407-11-194","article-title":"Major histocompatibility complex class I-related chain A\/B (MICA\/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA\/B expression","volume":"11","author":"Xu","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jare.2025.08.031_b1365","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","article-title":"Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation","volume":"419","author":"Groh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.08.031_b1370","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1073\/pnas.1632807100","article-title":"Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis","volume":"100","author":"Groh","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2025.08.031_b1375","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1084\/jem.20161707","article-title":"NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma","volume":"214","author":"Daley","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jare.2025.08.031_b1380","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10787-022-01026-7","article-title":"NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases","volume":"30","author":"Wang","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jare.2025.08.031_b1385","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00018-017-2720-9","article-title":"Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma","volume":"75","author":"Chen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jare.2025.08.031_b1390","doi-asserted-by":"crossref","first-page":"48972","DOI":"10.18632\/oncotarget.16903","article-title":"P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer","volume":"8","author":"Bae","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jare.2025.08.031_b1395","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13046-017-0589-y","article-title":"NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma","volume":"36","author":"Huang","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jare.2025.08.031_b1400","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jare.2025.08.031_b1405","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400938R","article-title":"UA influences the progression of breast cancer via the AhR\/p27Kip1\/cyclin E pathway","volume":"38","author":"Wang","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.jare.2025.08.031_b1410","article-title":"Uric acid mediated the association between BMI and postmenopausal breast cancer incidence: a bidirectional mendelian randomization analysis and prospective cohort study","volume":"12","author":"Feng","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jare.2025.08.031_b1415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000872","article-title":"Nucleotide de novo synthesis increases breast cancer stemness and metastasis via cGMP-PKG-MAPK signaling pathway","volume":"18","author":"Lv","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jare.2025.08.031_b1420","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.amjms.2024.07.005","article-title":"Associations between serum uric acid and breast cancer incidence: a systematic review and meta-analysis","volume":"368","author":"Xue","year":"2024","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jare.2025.08.031_b1425","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/bjc.2017.313","article-title":"Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study","volume":"117","author":"K\u00fchn","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jare.2025.08.031_b1430","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1007\/s00432-023-04725-y","article-title":"J-shaped association between uric acid and breast cancer risk: a prospective case-control study","volume":"149","author":"Fan","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1435","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3748\/wjg.v17.i6.727","article-title":"Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC\/MS","volume":"17","author":"Hu","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jare.2025.08.031_b1440","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1415421","article-title":"Prognostic significance of serum uric acid and gamma-glutamyltransferase in patients with advanced gastric cancer","volume":"2019","author":"Yang","year":"2019","journal-title":"Dis Markers"},{"key":"10.1016\/j.jare.2025.08.031_b1445","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1482814","article-title":"U-shaped relationship between serum uric acid and gastric cancer risk: a large prospective cohort study","volume":"14","author":"Huang","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1450","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1449205","article-title":"Fatty acid traits mediate the effects of uric acid on cancers: a Mendelian randomization study","volume":"15","author":"Li","year":"2024","journal-title":"Front Genet"},{"key":"10.1016\/j.jare.2025.08.031_b1455","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4236\/ojepi.2020.104032","article-title":"Serum uric acid level has stronger correlations with metabolic syndrome-related markers in women than in men in a Japanese health check-up population","volume":"10","author":"Seki","year":"2020","journal-title":"Open J Epidemiol"},{"key":"10.1016\/j.jare.2025.08.031_b1460","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/acr.25338","article-title":"Prevalence and associations between metabolic syndrome components and hyperuricemia by race: findings from US population, 2011-2020","volume":"76","author":"Kim","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jare.2025.08.031_b1465","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3390\/jcm9061635","article-title":"Association between non-alcoholic fatty liver disease and chronic kidney disease: a cross-sectional study","volume":"9","author":"Akahane","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jare.2025.08.031_b1470","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/IBPC.S184685","article-title":"Hyperuricemia and hypertension: links and risks","volume":"12","author":"Stewart","year":"2019","journal-title":"Integr Blood Press Control"},{"key":"10.1016\/j.jare.2025.08.031_b1475","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.7150\/ijbs.72534","article-title":"Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance","volume":"18","author":"Zhang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b1480","first-page":"016","article-title":"Essentially new inhibitors of metastasis of malignant tumors for chemotherapy-sparing treatment","volume":"7","author":"Is","year":"2021","journal-title":"Global J Cancer Therapy"},{"key":"10.1016\/j.jare.2025.08.031_b1485","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1343000","article-title":"Prevalence and risk factors for hyperuricemia and hyperuricosuria in patients with hematologic malignancies","volume":"11","author":"Kunlayawutipong","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.jare.2025.08.031_b1490","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1592\/phco.26.6.806","article-title":"Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults","volume":"26","author":"McDonnell","year":"2006","journal-title":"Pharmacotherapy: J Human Pharmacol Drug Therapy"},{"key":"10.1016\/j.jare.2025.08.031_b1495","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/biomedicines10051012","article-title":"Tumor lysis syndrome: an endless challenge in onco-nephrology","volume":"10","author":"Lupu\u0219oru","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jare.2025.08.031_b1500","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1016\/j.ijrobp.2024.07.996","article-title":"Effect of blood uric acid on tumor regression response to preoperative neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"120","author":"He","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jare.2025.08.031_b1505","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ijc.33781","article-title":"Metabolic checkpoints and novel approaches for immunotherapy against cancer","volume":"150","author":"Li","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jare.2025.08.031_b1510","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1186\/s12885-022-09958-7","article-title":"Patient stratification based on urea cycle metabolism for exploration of combination immunotherapy in colon cancer","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jare.2025.08.031_b1515","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","article-title":"Nucleotide metabolism: a pan-cancer metabolic dependency","volume":"23","author":"Mullen","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2025.08.031_b1520","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/mc.23664","article-title":"Can uric acid affect the immune microenvironment in bladder cancer? A single-center multi-omics study","volume":"63","author":"Chen","year":"2024","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jare.2025.08.031_b1525","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jare.2025.08.031_b1530","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-022-01263-x","article-title":"Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy","volume":"15","author":"Wu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1535","article-title":"Integrated analysis of purine metabolism assists in predicting prognosis and treatment decisions for patients with lung adenocarcinoma","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jare.2025.08.031_b1540","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41565-024-01733-y","article-title":"An artificial metabzyme for tumour-cell-specific metabolic therapy","volume":"19","author":"Hu","year":"2024","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.jare.2025.08.031_b1545","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101175","article-title":"Blockade of purine metabolism reverses macrophage immunosuppression and enhances anti-tumor immunity in non-small cell lung cancer","volume":"78","author":"Yang","year":"2025","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jare.2025.08.031_b1550","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211016661","article-title":"urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis","volume":"13","author":"Sharma","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1555","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmed.2018.00160","article-title":"Physiology of hyperuricemia and urate-lowering treatments","volume":"5","author":"Benn","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jare.2025.08.031_b1560","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/antiox10111801","article-title":"Tumour microenvironment stress promotes the development of drug resistance","volume":"10","author":"Seebacher","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jare.2025.08.031_b1565","article-title":"Modulation of redox homeostasis: a strategy to overcome cancer drug resistance","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b1570","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/ijc.27494","article-title":"Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia","volume":"131","author":"Springer","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jare.2025.08.031_b1575","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","article-title":"Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level","volume":"47","author":"Siu","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1580","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","article-title":"Effect of allopurinol in chronic kidney disease progression and cardiovascular risk","volume":"5","author":"Goicoechea","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2025.08.031_b1585","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","article-title":"A role for uric acid in the progression of renal disease","volume":"13","author":"Kang","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2025.08.031_b1590","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.jare.2025.08.031_b1595","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1164\/rccm.200808-1274OC","article-title":"Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis","volume":"179","author":"Gasse","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jare.2025.08.031_b1600","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/1878-0261.12521","article-title":"Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses","volume":"13","author":"Tavassoly","year":"2019","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1605","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/1940-6207.CAPR-12-0249","article-title":"A randomized, placebo-controlled, preoperative trial of allopurinol in subjects with colorectal adenoma","volume":"6","author":"Puntoni","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jare.2025.08.031_b1610","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/jcph.1832","article-title":"Exploring the relationship between colorectal cancer and allopurinol: a taiwanese population-based propensity-matched case-control study","volume":"61","author":"Hsu","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b1615","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/pcan.2017.14","article-title":"Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study","volume":"20","author":"Shih","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1620","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1158\/1541-7786.MCR-08-0012","article-title":"Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand","volume":"6","author":"Yasuda","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jare.2025.08.031_b1625","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/2040622312462056","article-title":"Latest evidence on gout management: what the clinician needs to know","volume":"3","author":"Burns","year":"2012","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1630","doi-asserted-by":"crossref","DOI":"10.47583\/ijpsrr.2023.v78i02.014","article-title":"A review on lesch-nyhan syndrome: a rare inherited disorder with hypoxanthine-guanine phosphoribosyltransferase deficiency","volume":"78","author":"Andhi","year":"2023","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"Suppl 1","key":"10.1016\/j.jare.2025.08.031_b1635","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar1909","article-title":"Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics","volume":"8","author":"Terkeltaub","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jare.2025.08.031_b1640","first-page":"2199","article-title":"Celebrating versatility: febuxostat\u2019s multifaceted therapeutic application","volume":"13","author":"Kraev","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jare.2025.08.031_b1645","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jare.2025.08.031_b1650","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","article-title":"Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout","volume":"52","author":"Becker","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jare.2025.08.031_b1655","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejphar.2014.11.013","article-title":"The xanthine oxidase inhibitor Febuxostat reduces tissue uric acid content and inhibits injury-induced inflammation in the liver and lung","volume":"746","author":"Kataoka","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b1660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075527","article-title":"Febuxostat, an inhibitor of xanthine oxidase, suppresses lipopolysaccharide-induced MCP-1 production via MAPK phosphatase-1-mediated inactivation of JNK","volume":"8","author":"Nomura","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2025.08.031_b1665","article-title":"Cardiovascular safety of febuxostat and allopurinol in hyperuricemic patients with or without gout: a network meta-analysis","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jare.2025.08.031_b1670","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/pharmaceutics12100956","article-title":"The Encapsulation of febuxostat into emulsomes strongly enhances the cytotoxic potential of the drug on HCT 116 colon cancer cells","volume":"12","author":"Fahmy","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jare.2025.08.031_b1675","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.1096\/fj.201802415RR","article-title":"The emerging role of xanthine oxidase inhibition for suppression of breast cancer cell migration and metastasis associated with hypercholesterolemia","volume":"33","author":"Oh","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.jare.2025.08.031_b1680","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2352022","article-title":"Management of hypertension addressing hyperuricaemia: introduction of nano-based approaches","volume":"56","author":"Girigoswami","year":"2024","journal-title":"Ann Med"},{"key":"10.1016\/j.jare.2025.08.031_b1685","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/annonc\/mdv317","article-title":"FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk","volume":"26","author":"Spina","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1690","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehz199","article-title":"Cardiovascular disease and uric acid: is the not-so-innocent bystander becoming a true culprit and does the US black box warning for febuxostat indicate that not all uric acid lowering is beneficial?","volume":"40","author":"Messerli","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jare.2025.08.031_b1695","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2332956","article-title":"Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials","volume":"56","author":"Yang","year":"2024","journal-title":"Ann Med"},{"key":"10.1016\/j.jare.2025.08.031_b1700","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00018-022-04289-z","article-title":"Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin","volume":"79","author":"La Grotta","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jare.2025.08.031_b1705","doi-asserted-by":"crossref","first-page":"e2347","DOI":"10.1210\/clinem\/dgaa748","article-title":"Dapagliflozin added to verinurad plus febuxostat further reduces serum uric acid in hyperuricemia: the QUARTZ study","volume":"106","author":"Stack","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jare.2025.08.031_b1710","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1248\/bpb.b20-00597","article-title":"Renal reabsorptive transport of uric acid precursor xanthine by URAT1 and GLUT9","volume":"43","author":"Arakawa","year":"2020","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jare.2025.08.031_b1715","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7520632","article-title":"Impacts of sodium\/glucose cotransporter-2 inhibitors on circulating uric acid concentrations: a systematic review and meta-analysis","volume":"2022","author":"Akbari","year":"2022","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jare.2025.08.031_b1720","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/bdd.1909","article-title":"SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria","volume":"35","author":"Chino","year":"2014","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.jare.2025.08.031_b1725","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7150\/ijbs.33007","article-title":"Empagliflozin attenuates hyperuricemia by upregulation of ABCG2 via AMPK\/AKT\/CREB signaling pathway in type 2 diabetic mice","volume":"16","author":"Lu","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b1730","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.08.031_b1735","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41419-019-1646-6","article-title":"Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced \u03b2-catenin activation","volume":"10","author":"Hung","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1740","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/hepr.13247","article-title":"Spontaneous regression of hepatocellular carcinoma with reduction in angiogenesis-related cytokines after treatment with sodium-glucose cotransporter 2 inhibitor in a cirrhotic patient with diabetes mellitus","volume":"49","author":"Kawaguchi","year":"2019","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jare.2025.08.031_b1745","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10067-022-06356-z","article-title":"Comparative efficacy and safety of uricosuric agents in the treatment of gout or hyperuricemia: a systematic review and network meta-analysis","volume":"42","author":"Li","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b1750","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.925219","article-title":"Review of urate-lowering therapeutics: from the past to the future","volume":"13","author":"Jenkins","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b1755","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3899\/jrheum.121301","article-title":"Efficacy and tolerability of probenecid as urate-lowering therapy in gout; clinical experience in high-prevalence population","volume":"40","author":"Pui","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b1760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12012-011-9145-8","article-title":"The history and future of probenecid","volume":"12","author":"Robbins","year":"2012","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jare.2025.08.031_b1765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093058","article-title":"Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism","volume":"9","author":"Bhaskaracharya","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2025.08.031_b1770","first-page":"C761","article-title":"Probenecid, a gout remedy, inhibits pannexin 1 channels","volume":"295","author":"Silverman","year":"2008","journal-title":"Am J Phys Cell Phys"},{"key":"10.1016\/j.jare.2025.08.031_b1775","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122851","article-title":"Pannexin-1 expression in tumor cells correlates with colon cancer progression and survival","volume":"351","author":"Fierro-Arenas","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.jare.2025.08.031_b1780","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221081075","article-title":"Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment","volume":"14","author":"Buck","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b1785","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"2020 American College of Rheumatology Guideline for the Management of Gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b1790","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14740338.2019.1594771","article-title":"Safety and tolerability of available urate-lowering drugs: a critical review","volume":"18","author":"Strilchuk","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jare.2025.08.031_b1795","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000861","article-title":"Update on gout management: what is old and what is new","volume":"34","author":"Afinogenova","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b1800","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/1756-185X.13266","article-title":"Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan","volume":"21","author":"Yu","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1805","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1536\/ihj.20-114","article-title":"Randomized, open-label, cross-over comparison of the effects of benzbromarone and febuxostat on endothelial function in patients with hyperuricemia","volume":"61","author":"Nakata","year":"2020","journal-title":"Int Heart J"},{"key":"10.1016\/j.jare.2025.08.031_b1810","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.842717","article-title":"OAT10\/SLC22A13 acts as a renal urate re-absorber: clinico-genetic and functional analyses with pharmacological impacts","volume":"13","author":"Toyoda","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b1815","article-title":"Enhancing challenging target screening via multimodal protein-ligand contrastive","author":"Wang","year":"2024","journal-title":"Learning"},{"key":"10.1016\/j.jare.2025.08.031_b1820","article-title":"Lung adenocarcinoma-related target gene prediction and drug repositioning","volume":"13","author":"Huang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b1825","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1158\/0008-5472.CAN-22-3784","article-title":"A benzarone derivative inhibits EYA to suppress tumor growth in SHH medulloblastoma","volume":"84","author":"Hwang","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2025.08.031_b1830","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2165\/00002018-200831080-00002","article-title":"A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?","volume":"31","author":"Lee","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.jare.2025.08.031_b1835","article-title":"Optimizing gout treatment: a comprehensive review of current and emerging uricosurics","volume":"92","author":"Kaufmann","year":"2024","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jare.2025.08.031_b1840","doi-asserted-by":"crossref","first-page":"679","DOI":"10.47102\/annals-acadmedsg.V36N8p679","article-title":"Avoiding dialysis in tumour lysis syndrome: is urate oxidase effective? - A case report and review of literature","volume":"36","author":"Teo","year":"2007","journal-title":"Ann Acad Med Singap"},{"key":"10.1016\/j.jare.2025.08.031_b1845","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.853735","article-title":"Optimized UV-spectrophotometric assay to screen bacterial uricase activity using whole cell suspension","volume":"13","author":"Pugin","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jare.2025.08.031_b1850","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1073\/pnas.1320393111","article-title":"Evolutionary history and metabolic insights of ancient mammalian uricases","volume":"111","author":"Kratzer","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2025.08.031_b1855","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167935","article-title":"A therapeutic uricase with reduced immunogenicity risk and improved development properties","volume":"11","author":"Nyborg","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2025.08.031_b1860","article-title":"Directed evolution to improve the catalytic efficiency of urate oxidase from Bacillus subtilis","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2025.08.031_b1865","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1021\/acscatal.7b00901","article-title":"Catalytic mechanisms for cofactor-free oxidase-catalyzed reactions: reaction pathways of uricase-catalyzed oxidation and hydration of uric acid","volume":"7","author":"Wei","year":"2017","journal-title":"ACS Catal"},{"key":"10.1016\/j.jare.2025.08.031_b1870","first-page":"145","article-title":"New and improved strategies for the treatment of gout","volume":"3","author":"Dubchak","year":"2010","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1875","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13054-016-1382-6","article-title":"Acute kidney injury in critically ill cancer patients: an update","volume":"20","author":"Lameire","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.jare.2025.08.031_b1880","first-page":"129","article-title":"Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)","volume":"2","author":"Pession","year":"2008","journal-title":"Biologics"},{"key":"10.1016\/j.jare.2025.08.031_b1885","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/OTT.S103864","article-title":"Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase","volume":"10","author":"Alakel","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jare.2025.08.031_b1890","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1159\/000509934","article-title":"Prevention and treatment of tumor lysis syndrome in the era of onco-nephrology progress","volume":"45","author":"Matuszkiewicz-Rowinska","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jare.2025.08.031_b1895","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/anae.15955","article-title":"Management of adult patients with haematological malignancies in critical care","volume":"78","author":"Fizza Haider","year":"2023","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jare.2025.08.031_b1900","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41584-023-01066-5","article-title":"Emerging therapeutic options for refractory gout","volume":"20","author":"Jatuworapruk","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b1905","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40259-022-00517-x","article-title":"Enhancing the response rate to recombinant uricases in patients with gout","volume":"36","author":"Schlesinger","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.jare.2025.08.031_b1910","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/ar4318","article-title":"Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy","volume":"15","author":"Baraf","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jare.2025.08.031_b1915","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13075-018-1782-x","article-title":"Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase","volume":"20","author":"Mandell","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jare.2025.08.031_b1920","doi-asserted-by":"crossref","first-page":"14351","DOI":"10.1073\/pnas.1001072107","article-title":"Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo","volume":"107","author":"Hershfield","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2025.08.031_b1925","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2165\/11202830-000000000-00000","article-title":"Pegloticase: in treatment-refractory chronic gout","volume":"71","author":"Lyseng-Williamson","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.jare.2025.08.031_b1930","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar4497","article-title":"Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout","volume":"16","author":"Lipsky","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jare.2025.08.031_b1935","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.2147\/DDDT.S86884","article-title":"Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects","volume":"9","author":"Yoon","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jare.2025.08.031_b1940","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/annrheumdis-2018-eular.2078","article-title":"AB1038\u2005Pharmacokinetics, pharmacodynamics and safety of nc-2500, a novel xanthine oxidoreductase inhibitor, in healthy Japanese male subjects","volume":"77","author":"Hirano","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1945","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2337\/db20-494-P","article-title":"494-P: effects of a novel xanthine oxidase inhibitor, TMX-049, on urinary albumin excretion in patients with type 2 diabetes and albuminuria","volume":"69","author":"Bakris","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.jare.2025.08.031_b1950","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/annrheumdis-2021-eular.1284","article-title":"POS1130\u2005pharmacokinetics and serum urate lowering effects of AR882, a novel, potent and selective uricosuric agent, in patients with gout","volume":"80","author":"Shen","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1955","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/annrheumdis-2023-eular.3251","article-title":"Op0295 a 12-week, randomized, double-blinded, placebo-controlled, phase 2b study of safety, tolerability and efficacy of Ar882 in gout patients","volume":"82","author":"Wei","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1960","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/annrheumdis-2024-eular.3659","article-title":"POS0268\u2005AR882, a novel and selective URAT1 inhibitor, significantly reduced tophi in patients with chronic gouty arthritis: results of 12-month outcome from a global trial using digital caliper measurements and dual energy computed tomography","volume":"83","author":"Keenan","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1965","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.9501","article-title":"Trends in prevalence of gout among US asian adults, 2011-2018","volume":"6","author":"Yokose","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jare.2025.08.031_b1970","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/jpet.115.231647","article-title":"Stronger uricosuric effects of the novel selective URAT1 inhibitor UR-1102 lowered plasma urate in tufted capuchin monkeys to a greater extent than benzbromarone","volume":"357","author":"Ahn","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jare.2025.08.031_b1975","doi-asserted-by":"crossref","first-page":"A704","DOI":"10.1136\/annrheumdis-2013-eular.2081","article-title":"SAT0356 the therapeutic efficacy of the novel uricosuric agent UR-1102 for hyperuricemia and gout","volume":"72","author":"Ahn","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1980","first-page":"1","article-title":"Virtual screening and biological evaluation of natural products as urate transporter 1 (URAT1) inhibitors","author":"Du","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jare.2025.08.031_b1985","doi-asserted-by":"crossref","first-page":"14668","DOI":"10.1021\/acs.jmedchem.4c01480","article-title":"Discovery of a potent and orally bioavailable xanthine oxidase\/urate transporter 1 dual inhibitor as a potential treatment for hyperuricemia and gout","volume":"67","author":"Yang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.jare.2025.08.031_b1990","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211067304","article-title":"Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study","volume":"14","author":"Tang","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jare.2025.08.031_b1995","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1093\/rheumatology\/keab198","article-title":"Efficacy and safety of a selective URAT1 inhibitor SHR4640 in chinese subjects with hyperuricaemia: a randomized controlled phase II study","volume":"60","author":"Lin","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jare.2025.08.031_b2000","article-title":"Oral Treatment with an engineered uricase, ALLN-346, reduces hyperuricemia, and uricosuria in urate oxidase-deficient mice","volume":"7","author":"Pierzynowska","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jare.2025.08.031_b2005","article-title":"Enhancing the response rate to recombinant uricases in patients with gout","volume":"36","author":"N","year":"2022","journal-title":"BioDrugs : Clin Immunotherapeutics, Biopharmaceuticals and Gene Therapy"},{"key":"10.1016\/j.jare.2025.08.031_b2010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/rheumatology\/kead333","article-title":"The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTORTM) versus pegloticase for refractory gout","volume":"63","author":"Baraf","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jare.2025.08.031_b2015","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/annrheumdis-2019-eular.7769","article-title":"SAT0402\u2005SEL-212 PHASE 2 clinical study in symptomatic gout patients: immtor tolerogenic nanoparticles combined with pegadricase mitigates immunogenicity and enables sustained reduction of serum uric acid levels, low rate of gout flares and monthly dosing","volume":"78","author":"Smolinski","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2025.08.031_b2020","article-title":"Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies","author":"Bomalaski","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jare.2025.08.031_b2025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40266-016-0347-4","article-title":"Diacerein: benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO","volume":"33","author":"Pavelka","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jare.2025.08.031_b2030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41401-021-00640-5","article-title":"CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia","volume":"43","author":"Zhao","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jare.2025.08.031_b2035","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.34067\/KID.0001672021","article-title":"A Non-purine xanthine oxidoreductase inhibitor reduces albuminuria in patients with DKD: a randomized controlled trial","volume":"2","author":"Bakris","year":"2021","journal-title":"Kidney"},{"key":"10.1016\/j.jare.2025.08.031_b2040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/annrheumdis-2017-eular.3548","article-title":"THU0422\u2005SEL-212: enhanced serum uric acid control in hyperuricemic patients through selective mitigation of anti-drug antibodies against pegsiticase","volume":"76","author":"Sands","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2025.08.031_b2045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cger.2017.08.007","article-title":"Exercise and older adults","volume":"34","author":"Mora","year":"2018","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jare.2025.08.031_b2050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1152\/advan.00089.2017","article-title":"Exercise is medicine: student pharmacists\u2019 perceptions and knowledge of exercise prescription","volume":"42","author":"Dirks-Naylor","year":"2018","journal-title":"Adv Physiol Educ"},{"issue":"Suppl 3","key":"10.1016\/j.jare.2025.08.031_b2055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/sms.12581","article-title":"Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases","volume":"25","author":"Pedersen","year":"2015","journal-title":"Scand J Med Sci Sports"},{"key":"10.1016\/j.jare.2025.08.031_b2060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopha.2018.01.052","article-title":"Antacids\u2019 side effect hyperuricaemia could be alleviated by long-term aerobic exercise via accelerating ATP turnover rate","volume":"99","author":"Yuan","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jare.2025.08.031_b2065","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1519\/JSC.0b013e3181d09edf","article-title":"Comparative effect of interval and continuous training programs on serum uric acid in management of hypertension: a randomized controlled trial","volume":"25","author":"Lamina","year":"2011","journal-title":"J Strength Cond Res"},{"key":"10.1016\/j.jare.2025.08.031_b2070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/15438620802103700","article-title":"Effects of aerobic exercise on uric acid, total antioxidant activity, oxidative stress, and nitric oxide in human saliva","volume":"16","author":"Gonz\u00e1lez","year":"2008","journal-title":"Res Sports Med"},{"key":"10.1016\/j.jare.2025.08.031_b2075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302410","article-title":"Nonlinear dose-response association of moderate-to-vigorous physical activity with hyperuricemia in US adults: NHANES 2007-2018","volume":"19","author":"Zeng","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2025.08.031_b2080","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jshs.2020.07.008","article-title":"Roles and molecular mechanisms of physical exercise in cancer prevention and treatment","volume":"10","author":"Wang","year":"2021","journal-title":"J Sport Health Sci"},{"key":"10.1016\/j.jare.2025.08.031_b2085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/ITT.S73223","article-title":"The role of adipokines in chronic inflammation","volume":"5","author":"Mancuso","year":"2016","journal-title":"ImmunoTargets Ther"},{"key":"10.1016\/j.jare.2025.08.031_b2090","article-title":"Muscle-to-tumor crosstalk: the effect of exercise-induced myokine on cancer progression","volume":"1877","author":"Huang","year":"2022","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jare.2025.08.031_b2095","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59996","article-title":"Cytotoxic T-cells mediate exercise-induced reductions in tumor growth","volume":"9","author":"Rundqvist","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jare.2025.08.031_b2100","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2016.01.011","article-title":"Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK Cell mobilization and redistribution","volume":"23","author":"Pedersen","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.08.031_b2105","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1200\/JCO.2006.08.2024","article-title":"Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial","volume":"25","author":"Courneya","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b2110","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2396075","article-title":"Exercise and hyperuricemia: an opinion article","volume":"56","author":"Zhang","year":"2024","journal-title":"Ann Med"},{"key":"10.1016\/j.jare.2025.08.031_b2115","first-page":"1205","article-title":"Changes in electrolytes and uric acid excretion during and after a 100 km run","volume":"32","author":"Wo\u0142yniec","year":"2018","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.jare.2025.08.031_b2120","doi-asserted-by":"crossref","first-page":"10790","DOI":"10.3390\/ijms221910790","article-title":"Inhibition of mitochondrial metabolism leads to selective eradication of cells adapted to acidic microenvironment","volume":"22","author":"Konco\u0161ov\u00e1","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b2125","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00018-019-03398-6","article-title":"TGF\u03b2-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer","volume":"77","author":"Hua","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jare.2025.08.031_b2130","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1186\/s12885-024-12367-7","article-title":"The selective sponging of miRNAs by OIP5-AS1 regulates metabolic reprogramming of pyruvate in adenoma-carcinoma transition of human colorectal cancer","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jare.2025.08.031_b2135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12937-024-00953-1","article-title":"Nonlinear relationship between oxidative balance score and hyperuricemia: analyses of NHANES 2007-2018","volume":"23","author":"Liu","year":"2024","journal-title":"Nutr J"},{"key":"10.1016\/j.jare.2025.08.031_b2140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13098-017-0212-6","article-title":"The waist circumference-adjusted associations between hyperuricemia and other lifestyle-related diseases","volume":"9","author":"Miyagami","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jare.2025.08.031_b2145","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3390\/nu15081806","article-title":"Association between dietary acid load and hyperuricemia in Chinese adults: analysis of the China health and nutrition survey (2009)","volume":"15","author":"Zhang","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.jare.2025.08.031_b2150","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22930","article-title":"Association between the dietary inflammatory index and gout in the national health and nutrition examination survey 2007-2018","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jare.2025.08.031_b2155","doi-asserted-by":"crossref","first-page":"12394","DOI":"10.3390\/ijms222212394","article-title":"Uric Acid in Inflammation and the pathogenesis of atherosclerosis","volume":"22","author":"Kimura","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.08.031_b2160","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/nu11081736","article-title":"Uric acid and plant-based nutrition","volume":"11","author":"Jak\u0161e","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jare.2025.08.031_b2165","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1007\/s00394-022-02892-1","article-title":"Dietary score associations with markers of chronic low-grade inflammation: a cross-sectional comparative analysis of a middle- to older-aged population","volume":"61","author":"Millar","year":"2022","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.jare.2025.08.031_b2170","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.3390\/ijerph20043596","article-title":"High-fructose diet-induced hyperuricemia accompanying metabolic syndrome-mechanisms and dietary therapy proposals","volume":"20","author":"Lubawy","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jare.2025.08.031_b2175","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/antiox12081554","article-title":"Plasma fatty acid composition, oxidative and inflammatory status, and adherence to the mediterranean diet of patients with non-alcoholic fatty liver disease","volume":"12","author":"Monserrat-Mesquida","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jare.2025.08.031_b2180","first-page":"383","article-title":"Polyphenol-rich and alcoholic beverages and metabolic status in adults living in sicily","volume":"10","author":"Micek","year":"2021","journal-title":"Southern Italy Foods"},{"key":"10.1016\/j.jare.2025.08.031_b2185","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2019.110620","article-title":"Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features","volume":"71","author":"Bull\u00f3n-Vela","year":"2020","journal-title":"Nutrition"},{"key":"10.1016\/j.jare.2025.08.031_b2190","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.3748\/wjg.v23.i17.3150","article-title":"Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease","volume":"23","author":"Gelli","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jare.2025.08.031_b2195","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/542698","article-title":"Diet, inflammation, and glycemic control in type 2 diabetes: an integrative review of the literature","volume":"2012","author":"Nowlin","year":"2012","journal-title":"J Nutr Metab"},{"key":"10.1016\/j.jare.2025.08.031_b2200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/S000711451800137X","article-title":"Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial","volume":"120","author":"Katsagoni","year":"2018","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jare.2025.08.031_b2205","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3945\/ajcn.2008.26956","article-title":"Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women\u2019s Health Initiative Dietary Modification Trial","volume":"89","author":"McTiernan","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jare.2025.08.031_b2210","doi-asserted-by":"crossref","first-page":"676","DOI":"10.36660\/abc.20210739","article-title":"How can we favorably modulate serum uric acid?","volume":"117","author":"Antoniazzi","year":"2021","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jare.2025.08.031_b2215","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.3390\/nu12123860","article-title":"Nutritional approaches for the management of nonalcoholic fatty liver disease: an evidence-based review","volume":"12","author":"Parra-Vargas","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jare.2025.08.031_b2220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12902-021-00856-w","article-title":"The Mediterranean diet and dietary approach to stop hypertension (DASH)-style diet are differently associated with lipid profile in a large sample of iranian adults: a cross-sectional study of Shahedieh cohort","volume":"21","author":"Panbehkar-Jouybari","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jare.2025.08.031_b2225","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3390\/nu12102983","article-title":"Dietary strategies for metabolic syndrome: a comprehensive review","volume":"12","author":"Castro-Barquero","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jare.2025.08.031_b2230","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3390\/nu12113232","article-title":"Diet quality, saturated fat and metabolic syndrome","volume":"12","author":"Harrison","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jare.2025.08.031_b2235","doi-asserted-by":"crossref","DOI":"10.31031\/GJEM.2018.01.000525","article-title":"The role of diet therapy in the patients treatment with hyperuricemia and metabolic syndrome","volume":"1","author":"Km","year":"2018","journal-title":"GJEM"},{"key":"10.1016\/j.jare.2025.08.031_b2240","doi-asserted-by":"crossref","first-page":"220","DOI":"10.32471\/exp-oncology.2312-8852.vol-42-no-3.15068","article-title":"Comparative evaluation of purine dysmetabolism in gastric and pulmonary adenocarcinomas","volume":"42","author":"Dumanskiy","year":"2020","journal-title":"Exp Oncol"},{"key":"10.1016\/j.jare.2025.08.031_b2245","doi-asserted-by":"crossref","first-page":"108571","DOI":"10.18632\/oncotarget.21010","article-title":"NLRP3 inflammasome activation plays a carcinogenic role through effector cytokine IL-18 in lymphoma","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jare.2025.08.031_b2250","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2011.10.001","article-title":"Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma","volume":"314","author":"Dunn","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jare.2025.08.031_b2255","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1139\/cjpp-2018-0731","article-title":"Effect of febuxostat on biochemical parameters of hyperlipidemia induced by a high-fat diet in rabbits","volume":"97","author":"Heikal","year":"2019","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.jare.2025.08.031_b2260","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110833","article-title":"Amino acid derivative of probenecid potentiates apoptosis-inducing effects of vinblastine by increasing oxidative stress in a cancer cell-specific manner","volume":"388","author":"Huttunen","year":"2024","journal-title":"Chem Biol Interact"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225006460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225006460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T19:27:23Z","timestamp":1776886043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225006460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":452,"alternative-id":["S2090123225006460"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.08.031","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum uric acid and its metabolism-a vital factor in the inflammatory transformation of cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}